Clinical trial
A Prospective Study of RejuvenAir™ System Radial Spray Cryotherapy to Determine Safety and Histological Effect in the Lung
NCT02106143 is registered in ClinicalTrials.gov with CSA Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of RejuvenAir™ System Radial Spray Cryotherapy to Determine Safety and Histological Effect in the Lung
- Lead sponsor
- CSA Medical, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- October 31, 2015
- Enrollment
- 11 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
airway obstruction, lung cancer, lung neoplasms